Melanie Hutton

Dr

  • 19 Innovation Walk, Monash BDI

20102020
If you made any changes in Pure these will be visible here soon.

Personal profile

Research area keywords

  • Clostridium difficile
  • mouse models
  • pathogenesis

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2018 2020

Research Output 2010 2020

Repurposing auranofin as a Clostridioides difficile therapeutic

Hutton, M. L., Pehlivanoglu, H., Vidor, C. J., James, M. L., Thomson, M. J. & Lyras, D., Feb 2020, In : Journal of Antimicrobial Chemotherapy. 75, 2, p. 409-417 9 p.

Research output: Contribution to journalArticleResearchpeer-review

3 Citations (Scopus)

A series of three cases of severe Clostridium difficile infection in Australia associated with a binary toxin producing clade 2 ribotype 251 strain

Wehrhahn, M. C., Keighley, C., Kurtovic, J., Knight, D. R., Hong, S., Hutton, M. L., Lyras, D., Wang, Q., Leong, R., Borody, T., Edye, M. & Riley, T. V., 1 Feb 2019, In : Anaerobe. 55, p. 117-123 7 p.

Research output: Contribution to journalArticleOtherpeer-review

Cationic biaryl 1,2,3-triazolyl peptidomimetic amphiphiles targeting Clostridioides (Clostridium) difficile: Synthesis, antibacterial evaluation and an in vivo C. difficile infection model

Tague, A. J., Putsathit, P., Hutton, M. L., Hammer, K. A., Wales, S. M., Knight, D. R., Riley, T. V., Lyras, D., Keller, P. A. & Pyne, S. G., 15 May 2019, In : European Journal of Medicinal Chemistry. 170, p. 203-224 22 p.

Research output: Contribution to journalArticleResearchpeer-review

3 Citations (Scopus)

Cephamycins inhibit pathogen sporulation and effectively treat recurrent Clostridioides difficile infection

Srikhanta, Y. N., Hutton, M. L., Awad, M. M., Drinkwater, N., Singleton, J., Day, S. L., Cunningham, B. A., McGowan, S. & Lyras, D., Dec 2019, In : Nature Microbiology. 4, p. 2237-2245 9 p.

Research output: Contribution to journalArticleResearchpeer-review

1 Citation (Scopus)

Hyperimmune bovine colostrum reduces gastrointestinal carriage of uropathogenic Escherichia coli

Larcombe, S., Hutton, M. L. & Lyras, D., 1 Feb 2019, In : Human Vaccines & Immunotherapeutics. 15, 2, p. 508-513 6 p.

Research output: Contribution to journalArticleResearchpeer-review